Puerto Rico
Prescription drug spending and prescribing in Puerto Rico, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $3.1B for prescriptions written in Puerto Rico, the 29th most of 52 states and territories, and 0.6% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $3.1B
- Medicaid drugs, 2025: $1.4B
- Opioid share of claims: 0.6%
- Life-science raises, 2 years: $4M
Opioid Share of Part D Claims, 2024
Puerto Rico outlined; every state in quartiles. Click a state to compare.
- Up to 3.2%
- 3.2% to 3.7%
- 3.7% to 4.3%
- Over 4.3%
Puerto Rico Against the Nation
Share of Part D claims; dark is the state, light the US.
- Opioids, Puerto Rico0.6%
- Opioids, US3.5%
- Antibiotics, Puerto Rico2.9%
- Antibiotics, US4.4%
- Antipsychotics, Puerto Rico1.6%
- Antipsychotics, US1.7%
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Puerto Rico | United States | Difference |
|---|---|---|---|
| Opioids | 0.6% | 3.5% | -83% |
| Antibiotics | 2.9% | 4.4% | -35% |
| Antipsychotics | 1.6% | 1.7% | -11% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Puerto Rico's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Diclofenac Potassium | 20.7× | 140,692 |
| Nabumetone | 13.0× | 137,616 |
| Pentoxifylline | 12.2× | 79,809 |
| Candesartan Cilexetil | 10.9× | 97,931 |
| Syringe-Needle,insulin,0.5 Ml | 9.7× | 80,533 |
| Temazepam | 9.2× | 370,456 |
| Irbesartan/Hydrochlorothiazide | 9.1× | 93,788 |
| Etodolac | 8.2× | 39,258 |
| Syringe And Needle,insulin,1ml | 8.0× | 72,210 |
| Galantamine Hbr | 7.5× | 35,930 |
Biggest Medicaid Drugs
What Puerto Rico's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
5 Form D raises by companies based in Puerto Rico in the last two years; the 10 largest. See all raises- MBQ PHARMA INC.$2M · Pharma · Aug 14, 2026
- MBQ PHARMA INC.$991K · Pharma · Aug 14, 2026
- MBQ PHARMA INC.$882K · Pharma · Aug 14, 2026
- MBQ PHARMA INC.$500K · Pharma · Aug 14, 2026
- MBQ PHARMA INC.$325K · Pharma · Aug 14, 2026
State Attorney General Health-Care Cases
Antitrust cases Puerto Rico joined, newest first; see every case- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Maryland v. SmithKline Beecham Corp., No. 2:06-cv-01298-JP (E.D.Pa Mar. 27, 2006)2006 · Settled
- Maryland et al. v. Perrigo Company, No. 1:04CV01398 (D.D.C. Aug. 17, 2004)2004 · Settled
- Texas et al. v. Organon (Remeron), No. 04-5126 (D.N.J. 2004)2004 · Settled
- In re Cardizem CD Antitrust Litigation 99-MD-1278 (E.D. Mich. Jan. 29, 2003), 332 F.3d 896 (6th Cir. 2003)2003 · Settled
- Ohio, et al, v. Bristol-Myers Squibb Co., et al.(D.D.C. 2002); see also In re Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL…2002 · Settled
- FTC and Puerto Rico v. College of Physician-Surgeons of Puerto Rico, No. 971 0011(D.P.R. Oct. 2. 1997)1997 · Settled
- In the Matter of GlaxoSmithKline, PLC (Augmentin)Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Ohio · Oklahoma · Oregon · Pennsylvania · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG